PatientID	Event Name	Event Type	Event Start	Event End	Event Table	Event Detail	Sex	Race
Patient 1	Diagnosis	Clinical Event	43.75	43.75	ClinicalAnnotation	Papillary Carcinoma	Male	Black or African American
Patient 1	Cisplatin	Medication	43.98	44.72	MedRegimen		Male	Black or African American
Patient 1	Gemcitabine Hydrochloride	Medication	43.98	44.72	MedRegimen		Male	Black or African American
Patient 1	Bladder Radiation	Radiation	45.23	45.48	Radiation	"Rad Dose: 2000, Rad Fraction: 5"	Male	Black or African American
Patient 1	Liver Metastasis	Metastatic Event	46.1	46.1	MetastaticDisease		Male	Black or African American
Patient 1	Pembrolizumab	Medication	46.35	47.25	MedRegimen		Male	Black or African American
Patient 1	Death	Clinical Event	49.45	49.45	ClinicalAnnotation		Male	Black or African American
Patient 2	Diagnosis	Clinical Event	67.24	67.24	ClinicalAnnotation	Adenocarcinoma	Male	White
Patient 2	Prostate Surgery	SurgeryTherapeutic	67.32	67.32	SurgeryTherapeutic	Therapeutic Surgery	Male	White
Patient 2	Prostate Sample Collection	Sample Collection	67.32	67.32	Pathology	RNA sequencing performed	Male	White
Patient 2	Abiraterone	Medication	67.56	68.23	MedRegimen		Male	White
Patient 2	Prostate Radiation	Radiation	68.47	68.68	Radiation	Rad Modality: External beam	Male	White
Patient 2	Imaging Prostate	Imaging	68.75	68.75	Imaging	"No evidence of disease, Surveillance Imaging"	Male	White
Patient 2	Complete Response	Positive Response	69.26	69.26	ClinicalAnnotation		Male	White
Patient 3	Diagnosis	Clinical Event	56.89	56.89	ClinicalAnnotation	Renal Cell Carcinoma	Female	White
Patient 3	Imaging Kidney	Imaging	56.89	56.89	Imaging	Diagnostic Imaging	Female	White
Patient 3	Kidney Biopsy	Surgery/Biopsy	56.92	56.92	SurgeryBiopsy	Diagnosit Biopsy	Female	White
Patient 3	Kidney Sample Collection	Sample Collection	56.92	56.92	Pathology	RNA and WES	Female	White
Patient 3	Pembrolizumab	Medication	57.05	57.59	MedRegimen		Female	White
Patient 3	Axitinib	Medication	57.05	57.59	MedRegimen		Female	White
Patient 3	Progressive Disease	Negative Response	57.47	57.47	ClinicalAnnotation		Female	White
Patient 3	Lung Metastasis	Metastatic Event	57.47	57.47	MetastaticDisease	Left lung lobe	Female	White
Patient 3	Radiation to Left Lung	Radiation	57.65	57.85	Radiation	"Rad Dose: 4500, Rad Fraction: 15"	Female	White
